gastric cancer
Mirxes Gets $40M Financing From CBC Group's R-Bridge to Support Global Expansion
The company is developing blood-based microRNA tests for early cancer detection and screening, with its flagship assay, GastroClear, already approved as an IVD in Singapore.
Phosphoproteomic Studies Point to Subtypes, Treatment Targets for Gastric, Prostate Cancer
Two independent research teams characterized proteomic and phosphoproteomic patterns in the two cancer types using matched tumor and normal tissues.
BostonGene, Duke University School of Medicine Strike Cancer Research Alliance
The partners plan to collaborate on research projects across a range of cancers with the goal of improving patient responses to treatment.
FDA Grants Marketing Authorization for Invitae Hereditary Cancer DNA Sequencing Test
The Invitae Common Hereditary Cancers Panel is the first test of its kind to obtain FDA marketing authorization, creating an easier pathway for similar tests.
CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval
The test is used to detect human platelet-derived growth factor receptor alpha gene mutations in gastrointestinal stromal tumors.